D3.77 - Tattoo Ink Allergy? Diagnostic Challenges in Cutaneous Reactions to Tattoo Ink Containing Metals

Background: Adverse cutaneous reactions to tattoo pigments are increasingly reported, yet their underlying mechanisms remain poorly understood. Differentiating allergic contact dermatitis from toxic reactions remain challenging, particularly when diagnostic testing is limited and cause incongruent results.

Case report: We report a patient who developed a localized cutaneous reaction following tattooing with black ink. Clinical examination revealed erythematous plaques and erosions with yellow crusting confined to the tattooed area on the front upper right side of the chest. Intravenous antibiotic and topical anti-inflammatory and antiseptic treatment was initiated.

Later, an allergy workup was performed, including patch testing to standard allergens, disinfectants and metals, as well as chemical analysis of the tattoo ink allegedly used by the artist. Patch testing demonstrated a reaction to mercury, despite absence of mercury in the ink composition. Conversely, cobalt was identified in high doses (11.9 mg/kg) in the ink, yet patch testing to cobalt was negative. No other relevant allergens were identified by the analysis, but the ink contained many unidentified contaminants.

Discussion: This case illustrates the diagnostic complexity of tattoo-associated cutaneous reactions. The first challenge is to identify the correct ingredients. Collaboration with a specialized laboratory, if available, is recommended to fully analyse the ink. The second challenge is to perform the patch testing with substances with a high sensitivity and specificity. Since certain metals can also cause irritation, the reactions during patch testing must be interpreted with caution. In the case of mercury, irritative reactions have also been described. Other options would be in vitro testing using lymphocyte transformation testing for metals, but this has not yet been standardised. Finally, the cutaneous reaction may also be investigated further. While tattoo pigments can trigger T-cell-mediated delayed-type allergies, these substances can also induce toxic reactions. Chemical transformation of pigments within the dermis, including degradation or hapten formation, further complicates interpretation of diagnostic results.

Conclusion: Our case underscores the challenges in establishing causality in tattoo-related cutaneous reactions when patch testing and ink analysis are discordant. Improved diagnostic tools and standardized testing protocols are needed to better characterize adverse reactions to tattoo pigments and to guide patient counselling and clinical decision-making.